More states consider dropping GLP-1 weight loss drugs from Medicaid
Massachusetts and Rhode Island are considering dropping GLP-1 drugs for obesity treatment from their Medicaid programs, continuing a trend of states that have stopped coverage of these expensive medications. Thirteen state Medicaid programs are covering GLP-1 drugs for the treatment of obesity this year, down from 16 last year. Medicaid programs in California, New Hampshire, […]
📰 Original Source
Read full article at Nebraskaexaminer →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.